315 related articles for article (PubMed ID: 19519381)
1. Homochiral drugs: a demanding tendency of the pharmaceutical industry.
Núñez MC; García-Rubiño ME; Conejo-García A; Cruz-López O; Kimatrai M; Gallo MA; Espinosa A; Campos JM
Curr Med Chem; 2009; 16(16):2064-74. PubMed ID: 19519381
[TBL] [Abstract][Full Text] [Related]
2. [Chiral switch: towards a better benefit-risk ratio?].
Blin O
Therapie; 2004; 59(6):625-8. PubMed ID: 15789826
[TBL] [Abstract][Full Text] [Related]
3. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
Miller CP; Ullrich JW
Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
[TBL] [Abstract][Full Text] [Related]
4. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.
Calcaterra A; D'Acquarica I
J Pharm Biomed Anal; 2018 Jan; 147():323-340. PubMed ID: 28942107
[TBL] [Abstract][Full Text] [Related]
5. Biocatalysis: synthesis of chiral intermediates for drugs.
Patel RN
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
[TBL] [Abstract][Full Text] [Related]
6. Approaches for multi-gram scale isolation of enantiomers for drug discovery.
Rossi D; Tarantino M; Rossino G; Rui M; Juza M; Collina S
Expert Opin Drug Discov; 2017 Dec; 12(12):1253-1269. PubMed ID: 28971706
[TBL] [Abstract][Full Text] [Related]
7. Racemates or enantiomers: regulatory approaches.
Birkett DJ
Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):479-83. PubMed ID: 2670355
[TBL] [Abstract][Full Text] [Related]
8. [Chiral switch: pure enantiomers of drugs instead of racemic mixtures].
Valentová J; Hutt AJ
Ceska Slov Farm; 2004 Nov; 53(6):285-93. PubMed ID: 15630994
[TBL] [Abstract][Full Text] [Related]
9. Trends in the development of chiral drugs.
Caner H; Groner E; Levy L; Agranat I
Drug Discov Today; 2004 Feb; 9(3):105-10. PubMed ID: 15038394
[No Abstract] [Full Text] [Related]
10. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
Aboul-Enein HY; El-Awady MI; Heard CM; Nicholls PJ
Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
[TBL] [Abstract][Full Text] [Related]
11. Membrane Bioreactors for Pharmaceutical Applications: Optically Pure Enantiomers Production.
Piacentini E; Mazzei R; Giorno L
Curr Pharm Des; 2017; 23(2):250-262. PubMed ID: 27881063
[TBL] [Abstract][Full Text] [Related]
12. Scalable enantioselective processes for chiral pharmaceutical intermediates.
Iida T; Mase T
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of chiral building blocks for use in drug discovery.
Marino ST; Stachurska-Buczek D; Huggins DA; Krywult BM; Sheehan CS; Nguyen T; Choi N; Parsons JG; Griffiths PG; James IW; Bray AM; White JM; Boyce RS
Molecules; 2004 May; 9(6):405-26. PubMed ID: 18007441
[TBL] [Abstract][Full Text] [Related]
14. Chiral switches.
Tucker GT
Lancet; 2000 Mar; 355(9209):1085-7. PubMed ID: 10744105
[TBL] [Abstract][Full Text] [Related]
15. Chiral Aspects of Local Anesthetics.
Čižmáriková R; Čižmárik J; Valentová J; Habala L; Markuliak M
Molecules; 2020 Jun; 25(12):. PubMed ID: 32545678
[TBL] [Abstract][Full Text] [Related]
16. [Preparations and biological properties of chiral compounds].
Sinko G
Arh Hig Rada Toksikol; 2005 Dec; 56(4):351-61. PubMed ID: 16370519
[TBL] [Abstract][Full Text] [Related]
17. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
[TBL] [Abstract][Full Text] [Related]
18. Analytical and Preparative Scale Separation of Enantiomers of Chiral Drugs by Chromatography and Related Methods.
Gumustas M; Ozkan SA; Chankvetadze B
Curr Med Chem; 2018; 25(33):4152-4188. PubMed ID: 29376488
[TBL] [Abstract][Full Text] [Related]
19. Differential properties of enantiomers of commercially available racemates.
Gulati V
J Indian Med Assoc; 2007 Apr; 105(4):173-4, 176. PubMed ID: 17822184
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologically active compounds in the environment and their chirality.
Kasprzyk-Hordern B
Chem Soc Rev; 2010 Nov; 39(11):4466-503. PubMed ID: 20852776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
